Annotation Detail for ITGAM
Basic Information Top
Gene Symbol: | ITGAM ( CD11B,CR3A,MAC-1,MAC1A,MGC117044,MO1A,SLEB6 ) |
---|---|
Gene Full Name: | integrin, alpha M (complement component 3 receptor 3 subunit) |
Band: | 16p11.2 |
Quick Links | Entrez ID:3684; OMIM: 120980; Uniprot ID:ITAM_HUMAN; ENSEMBL ID: ENSG00000169896; HGNC ID: 6149 |
Relate to Another Database: | SFARIGene; denovo-db |
No data |
Pathway ID | Pathway Name |
---|---|
hsa04670 | Leukocyte transendothelial migration |
hsa04640 | Hematopoietic cell lineage |
hsa04145 | Phagosome |
hsa05140 | Leishmaniasis |
hsa05146 | Amoebiasis |
hsa05150 | Staphylococcus aureus infection |
hsa04810 | Regulation of actin cytoskeleton |
hsa04514 | Cell adhesion molecules (CAMs) |
Pathway ID | Pathway Name |
---|---|
Hemostasis | |
Integrin cell surface interactions |
Pathway ID | Pathway Name |
---|---|
200108 | amb2 Integrin signaling |
Pathway ID | Pathway Name |
---|---|
P00034 | Integrin signalling pathway |
No data |
No data |
Desease ID | Desease Name |
---|---|
1706 | Thrombophilia |
1712 | Yersinia infection |
1740 | Alzheimer's disease |
1770 | Melanoma |
1804 | Chronic obstructive airway disease |
1902 | Kidney failure |
1904 | Diabetes mellitus |
1929 | Pertussis |
2051 | Leukemia |
2111 | Systemic infection |
2146 | Lupus erythematosus |
Desease Name |
---|
Lupus Erythematosus, Systemic |
systemic lupus erythematosus |
nephritis |
IMMUNE |
Desease Name |
---|
Systemic lupus erythematosus |
Desease Name |
---|
Systemic lupus erythematous, association with susceptibility to, 6 |
Chemical ID | Chemical Name | Interaction | Interaction Action | Publication |
---|---|---|---|---|
C120227 | 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide | 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide inhibits the reaction [Tretinoin results in increased expression of ITGAM protein] | decreases reaction|increases expression | 17077328 |
C490707 | 2-(4-isobutylphenyl)propionylmethanesulfonamide | 2-(4-isobutylphenyl)propionylmethanesulfonamide inhibits the reaction [IL8 protein results in increased expression of ITGAM protein] | decreases reaction|increases expression | 15652230 |
C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [CCL11 protein results in increased expression of ITGAM protein] | decreases reaction|increases expression | 11980903 |
C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Tretinoin results in increased expression of ITGAM protein] | decreases reaction|increases expression | 16617325 |
C002010 | 4-(2-aminoethyl)benzenesulfonylfluoride | 4-(2-aminoethyl)benzenesulfonylfluoride inhibits the reaction [Tetradecanoylphorbol Acetate results in increased localization of ITGAM protein] | decreases reaction|increases localization | 10739673 |
C090942 | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [CCL11 protein results in increased expression of ITGAM protein] | decreases reaction|increases expression | 11980903 |
C090942 | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Indomethacin results in increased expression of ITGAM protein] | decreases reaction|increases expression | 11980903 |
D000082 | Acetaminophen | Acetaminophen affects the expression of ITGAM mRNA | affects expression | 17562736 |
C056165 | acetovanillone | acetovanillone inhibits the reaction [Fatty Acids, Nonesterified results in increased expression of ITGAM mRNA] | decreases reaction|increases expression | 16357311 |
C103303 | alitretinoin | Dimethyl Sulfoxide promotes the reaction [alitretinoin results in increased expression of ITGAM protein] | increases expression|increases reaction | 15964820 |
C103303 | alitretinoin | Vitamin D promotes the reaction [alitretinoin results in increased expression of ITGAM protein] | increases expression|increases reaction | 15964820 |
D000643 | Ammonium Chloride | Ammonium Chloride affects the expression of ITGAM mRNA | affects expression | 16483693 |
D001151 | Arsenic | Arsenic results in decreased expression of ITGAM mRNA | decreases expression | 19654921 |
C058317 | arsenic disulfide | arsenic disulfide results in increased expression of ITGAM protein | increases expression | 19996592 |
C058317 | arsenic disulfide | Hydrogen Peroxide promotes the reaction [arsenic disulfide results in increased expression of ITGAM protein] | increases expression|increases reaction | 19996592 |
C006632 | arsenic trioxide | arsenic trioxide results in increased expression of ITGAM mRNA | increases expression | 16468075 |
C006632 | arsenic trioxide | arsenic trioxide results in increased expression of ITGAM protein | increases expression | 16430862 |
C006632 | arsenic trioxide | [Tretinoin co-treated with arsenic trioxide] results in increased expression of ITGAM mRNA | affects cotreatment|increases expression | 16468075 |
C055494 | caffeic acid phenethyl ester | caffeic acid phenethyl ester promotes the reaction [Tretinoin results in increased expression of ITGAM protein] | increases expression|increases reaction | 16766008 |
C055494 | caffeic acid phenethyl ester | caffeic acid phenethyl ester results in increased expression of ITGAM protein | increases expression | 16766008 |
C014347 | decitabine | decitabine affects the expression of ITGAM mRNA | affects expression | 18460780 |
D004041 | Dietary Fats | Dietary Fats results in decreased expression of ITGAM mRNA | decreases expression | 18042831 |
D002117 | Calcitriol | Calcitriol results in increased expression of ITGAM protein | increases expression | 14729647 |
D004121 | Dimethyl Sulfoxide | Dimethyl Sulfoxide promotes the reaction [alitretinoin results in increased expression of ITGAM protein] | increases expression|increases reaction | 15964820 |
D004121 | Dimethyl Sulfoxide | Dimethyl Sulfoxide results in increased expression of ITGAM protein | increases expression | 16617325 |
C007517 | diphenyleneiodonium | diphenyleneiodonium inhibits the reaction [Fatty Acids, Nonesterified results in increased expression of ITGAM mRNA] | decreases reaction|increases expression | 16357311 |
D005230 | Fatty Acids, Nonesterified | acetovanillone inhibits the reaction [Fatty Acids, Nonesterified results in increased expression of ITGAM mRNA] | decreases reaction|increases expression | 16357311 |
D005230 | Fatty Acids, Nonesterified | diphenyleneiodonium inhibits the reaction [Fatty Acids, Nonesterified results in increased expression of ITGAM mRNA] | decreases reaction|increases expression | 16357311 |
D005230 | Fatty Acids, Nonesterified | Fatty Acids, Nonesterified results in increased expression of ITGAM mRNA | increases expression | 16357311 |
D005230 | Fatty Acids, Nonesterified | Glutathione inhibits the reaction [Fatty Acids, Nonesterified results in increased expression of ITGAM mRNA] | decreases reaction|increases expression | 16357311 |
D005419 | Flavonoids | Flavonoids results in decreased expression of ITGAM mRNA | decreases expression | 18035473 |
D009240 | N-Formylmethionine Leucyl-Phenylalanine | N-Formylmethionine Leucyl-Phenylalanine results in increased expression of ITGAM protein | increases expression | 10215738 15774851 11116075 |
D009240 | N-Formylmethionine Leucyl-Phenylalanine | plaunotol inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased expression of ITGAM protein] | decreases reaction|increases expression | 10215738 |
D009240 | N-Formylmethionine Leucyl-Phenylalanine | SR 27417 inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased expression of ITGAM protein] | decreases reaction|increases expression | 11116075 |
D005978 | Glutathione | Glutathione inhibits the reaction [Fatty Acids, Nonesterified results in increased expression of ITGAM mRNA] | decreases reaction|increases expression | 16357311 |
D006830 | Hydralazine | [Hydralazine co-treated with Valproic Acid] results in decreased expression of ITGAM mRNA | affects cotreatment|decreases expression | 17183730 |
D006861 | Hydrogen Peroxide | Hydrogen Peroxide promotes the reaction [arsenic disulfide results in increased expression of ITGAM protein] | increases expression|increases reaction | 19996592 |
D019796 | 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid results in increased expression of ITGAM protein | increases expression | 11116075 |
D019796 | 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | ICI 192605 inhibits the reaction [15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid results in increased expression of ITGAM protein] | decreases reaction|increases expression | 11116075 |
C057498 | ICI 192605 | ICI 192605 inhibits the reaction [15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid results in increased expression of ITGAM protein] | decreases reaction|increases expression | 11116075 |
D007213 | Indomethacin | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Indomethacin results in increased expression of ITGAM protein] | decreases reaction|increases expression | 11980903 |
D007213 | Indomethacin | Indomethacin results in increased expression of ITGAM protein | increases expression | 11980903 |
D007213 | Indomethacin | Indomethacin results in increased expression of [ITGAM protein binds to ITGB2 protein] | affects binding|increases expression | 10761979 |
D007501 | Iron | Iron deficiency results in increased expression of ITGAM mRNA | increases expression | 20368581 |
D007501 | Iron | Iron deficiency results in increased expression of ITGAM protein | increases expression | 20368581 |
D007501 | Iron | Vitamin D promotes the reaction [Iron deficiency results in increased expression of ITGAM protein] | increases expression|increases reaction | 20368581 |
C063302 | KN 62 | KN 62 results in increased expression of ITGAM protein | increases expression | 17431504 |
D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of ITGAM protein | increases expression | 12734376 |
D008070 | Lipopolysaccharides | ITGAM protein affects the reaction [Lipopolysaccharides affects the localization of and results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|affects localization|affects reaction|increases activity | 11123339 |
D008070 | Lipopolysaccharides | ITGAM protein affects the reaction [Lipopolysaccharides results in increased expression of IL12A mRNA] | affects reaction|increases expression | 11123339 |
D008070 | Lipopolysaccharides | ITGAM protein affects the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | affects reaction|increases expression | 11123339 |
D008070 | Lipopolysaccharides | ITGAM protein affects the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein] | affects reaction|increases phosphorylation | 11123339 |
D008070 | Lipopolysaccharides | ITGAM protein affects the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK3 protein] | affects reaction|increases phosphorylation | 11123339 |
D008070 | Lipopolysaccharides | ITGAM protein affects the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK8 protein] | affects reaction|increases phosphorylation | 11123339 |
D008070 | Lipopolysaccharides | ITGAM protein affects the reaction [Lipopolysaccharides results in increased secretion of [IL12A protein binds to IL12B protein]] | affects binding|affects reaction|increases secretion | 11123339 |
D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of ITGAM protein | increases expression | 8566054 15328337 |
D008070 | Lipopolysaccharides | tepoxalin inhibits the reaction [Lipopolysaccharides results in increased expression of ITGAM protein] | decreases reaction|increases expression | 8566054 |
D008070 | Lipopolysaccharides | zileuton inhibits the reaction [Lipopolysaccharides results in increased expression of ITGAM protein] | decreases reaction|increases expression | 15328337 |
D015058 | 1-Naphthylisothiocyanate | 1-Naphthylisothiocyanate results in increased expression of ITGAM mRNA | increases expression | 12832660 |
C056709 | N,N-diacetylcystine | N,N-diacetylcystine results in decreased expression of ITGAM protein | decreases expression | 17157857 |
D010126 | Ozone | Ozone results in increased expression of ITGAM protein | increases expression | 15036748 |
D017239 | Paclitaxel | ITGAM protein affects the reaction [Paclitaxel affects the localization of and results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|affects localization|affects reaction|increases activity | 11123339 |
D017239 | Paclitaxel | ITGAM protein affects the reaction [Paclitaxel results in increased expression of IL12A mRNA] | affects reaction|increases expression | 11123339 |
D017239 | Paclitaxel | ITGAM protein affects the reaction [Paclitaxel results in increased expression of PTGS2 mRNA] | affects reaction|increases expression | 11123339 |
D017239 | Paclitaxel | ITGAM protein affects the reaction [Paclitaxel results in increased phosphorylation of MAPK1 protein] | affects reaction|increases phosphorylation | 11123339 |
D017239 | Paclitaxel | ITGAM protein affects the reaction [Paclitaxel results in increased phosphorylation of MAPK3 protein] | affects reaction|increases phosphorylation | 11123339 |
D017239 | Paclitaxel | ITGAM protein affects the reaction [Paclitaxel results in increased phosphorylation of MAPK8 protein] | affects reaction|increases phosphorylation | 11123339 |
D017239 | Paclitaxel | ITGAM protein affects the reaction [Paclitaxel results in increased secretion of [IL12A protein binds to IL12B protein]] | affects binding|affects reaction|increases secretion | 11123339 |
C041786 | palm oil | palm oil results in decreased expression of ITGAM mRNA | decreases expression | 18042831 |
C093973 | PD 98059 | PD 98059 inhibits the reaction [Tretinoin results in increased expression of ITGAM protein] | decreases reaction|increases expression | 16617325 |
D010634 | Phenobarbital | Phenobarbital results in increased expression of ITGAM mRNA | increases expression | 12832660 |
D010972 | Platelet Activating Factor | Platelet Activating Factor results in increased expression of ITGAM protein | increases expression | 11116075 |
D010972 | Platelet Activating Factor | SR 27417 inhibits the reaction [Platelet Activating Factor results in increased expression of ITGAM protein] | decreases reaction|increases expression | 11116075 |
C047686 | plaunotol | plaunotol inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased expression of ITGAM protein] | decreases reaction|increases expression | 10215738 |
C071317 | SR 27417 | SR 27417 inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased expression of ITGAM protein] | decreases reaction|increases expression | 11116075 |
C071317 | SR 27417 | SR 27417 inhibits the reaction [Platelet Activating Factor results in increased expression of ITGAM protein] | decreases reaction|increases expression | 11116075 |
D013619 | Tacrine | Tacrine results in increased expression of ITGAM mRNA | increases expression | 12832660 |
C021751 | tanshinone | tanshinone results in increased expression of ITGAM protein | increases expression | 16009009 |
C073135 | tepoxalin | tepoxalin inhibits the reaction [Lipopolysaccharides results in increased expression of ITGAM protein] | decreases reaction|increases expression | 8566054 |
D013755 | Tetradecanoylphorbol Acetate | 4-(2-aminoethyl)benzenesulfonylfluoride inhibits the reaction [Tetradecanoylphorbol Acetate results in increased localization of ITGAM protein] | decreases reaction|increases localization | 10739673 |
D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate results in increased expression of ITGAM protein | increases expression | 16430862 16617325 |
D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate results in increased localization of ITGAM protein | increases localization | 10739673 |
D013755 | Tetradecanoylphorbol Acetate | Tosyllysine Chloromethyl Ketone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased localization of ITGAM protein] | decreases reaction|increases localization | 10739673 |
D013755 | Tetradecanoylphorbol Acetate | Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased localization of ITGAM protein] | decreases reaction|increases localization | 10739673 |
D014107 | Tosyllysine Chloromethyl Ketone | Tosyllysine Chloromethyl Ketone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased localization of ITGAM protein] | decreases reaction|increases localization | 10739673 |
D014108 | Tosylphenylalanyl Chloromethyl Ketone | Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased localization of ITGAM protein] | decreases reaction|increases localization | 10739673 |
D014212 | Tretinoin | 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide inhibits the reaction [Tretinoin results in increased expression of ITGAM protein] | decreases reaction|increases expression | 17077328 |
D014212 | Tretinoin | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Tretinoin results in increased expression of ITGAM protein] | decreases reaction|increases expression | 16617325 |
D014212 | Tretinoin | AKT1 protein promotes the reaction [Tretinoin results in increased expression of ITGAM protein] | increases expression|increases reaction | 16617325 |
D014212 | Tretinoin | caffeic acid phenethyl ester promotes the reaction [Tretinoin results in increased expression of ITGAM protein] | increases expression|increases reaction | 16766008 |
D014212 | Tretinoin | CSF3 protein promotes the reaction [Tretinoin results in increased expression of ITGAM protein] | increases expression|increases reaction | 18055984 |
D014212 | Tretinoin | ICAM1 protein promotes the reaction [Tretinoin results in increased expression of ITGAM protein] | increases expression|increases reaction | 18055984 |
D014212 | Tretinoin | PD 98059 inhibits the reaction [Tretinoin results in increased expression of ITGAM protein] | decreases reaction|increases expression | 16617325 |
D014212 | Tretinoin | PTK2 protein inhibits the reaction [Tretinoin results in increased expression of ITGAM protein] | decreases reaction|increases expression | 16226872 |
D014212 | Tretinoin | TGFB1 protein promotes the reaction [Tretinoin results in increased expression of ITGAM protein] | increases expression|increases reaction | 16242776 |
D014212 | Tretinoin | [Tretinoin co-treated with arsenic trioxide] results in increased expression of ITGAM mRNA | affects cotreatment|increases expression | 16468075 |
D014212 | Tretinoin | Tretinoin results in increased expression of ITGAM mRNA | increases expression | 16322068 15988048 15770638 16468075 |
D014212 | Tretinoin | Tretinoin results in increased expression of ITGAM protein | increases expression | 18055984 16226872 16764927 17431504 16766008 16430862 17077328 16510162 15770638 16617325 15194426 |
D014415 | Tunicamycin | Tunicamycin results in increased expression of ITGAM mRNA | increases expression | 17127020 |
C113580 | U 0126 | U 0126 inhibits the reaction [CCL11 protein results in increased expression of ITGAM protein] | decreases reaction|increases expression | 11980903 |
D014635 | Valproic Acid | [Hydralazine co-treated with Valproic Acid] results in decreased expression of ITGAM mRNA | affects cotreatment|decreases expression | 17183730 |
C025643 | vinclozolin | vinclozolin results in increased expression of ITGAM mRNA | increases expression | 18629315 |
D014807 | Vitamin D | Vitamin D promotes the reaction [alitretinoin results in increased expression of ITGAM protein] | increases expression|increases reaction | 15964820 |
D014807 | Vitamin D | Vitamin D promotes the reaction [Iron deficiency results in increased expression of ITGAM protein] | increases expression|increases reaction | 20368581 |
D014807 | Vitamin D | Vitamin D results in increased expression of ITGAM mRNA | increases expression | 20368581 |
D002762 | Cholecalciferol | [Cholecalciferol co-treated with TGFB1 protein] results in increased expression of ITGAM mRNA | affects cotreatment|increases expression | 15988048 |
C063449 | zileuton | zileuton inhibits the reaction [Lipopolysaccharides results in increased expression of ITGAM protein] | decreases reaction|increases expression | 15328337 |
Disease ID | Disease Name | Direct Evidence | Inference Chemical Name | Inference Score | Publication |
---|---|---|---|---|---|
MESH:D000014 | Abnormalities, Drug-Induced | Phenobarbital | 6.67 | 6195326 | |
MESH:D000014 | Abnormalities, Drug-Induced | Valproic Acid | 6.67 | 8875741 | |
MESH:D000015 | Abnormalities, Multiple | Valproic Acid | 3.42 | 19490988 | |
MESH:D000138 | Acidosis | Ammonium Chloride | 3.00 | 18287403 | |
MESH:D000152 | Acne Vulgaris | zileuton | 5.19 | 20436887 | |
MESH:D000168 | Acrocephalosyndactylia | U 0126 | 4.93 | 17694057 | |
MESH:D055371 | Acute Lung Injury | Lipopolysaccharides | 8.00 | 11850527 18653653 | |
MESH:D055371 | Acute Lung Injury | zileuton | 8.00 | 17118201 | |
MESH:D000230 | Adenocarcinoma | arsenic trioxide | 4.06 | 11798837 19825857 | |
MESH:D000230 | Adenocarcinoma | Indomethacin | 4.06 | 16537180 | |
MESH:D000236 | Adenoma | Indomethacin | 3.11 | 11497255 | |
MESH:D018248 | Adenoma, Liver Cell | Phenobarbital | 3.41 | 17620307 | |
MESH:D018246 | Adrenocortical Adenoma | Arsenic | 4.64 | 17306315 | |
MESH:D000505 | Alopecia | Tretinoin | 3.16 | 15955085 | |
MESH:D019896 | alpha 1-Antitrypsin Deficiency | Iron | 5.08 | 16640825 | |
MESH:D016301 | Alveolar Bone Loss | Indomethacin | 4.79 | 17225004 | |
MESH:D000544 | Alzheimer Disease | Indomethacin | 8.19 | 17627676 15579461 | |
MESH:D000544 | Alzheimer Disease | Iron | 8.19 | 16563566 16640825 | |
MESH:D000544 | Alzheimer Disease | Ozone | 8.19 | 15513908 | |
MESH:D000544 | Alzheimer Disease | Tacrine | 8.19 | 12725862 | |
MESH:D000550 | Amblyopia | Valproic Acid | 4.66 | 17688650 | |
MESH:D000740 | Anemia | Iron | 3.88 | 16434484 16566752 | |
MESH:D018798 | Anemia, Iron-Deficiency | Iron | 4.15 | 17375513 16569441 17163184 17162259 17147795 | |
MESH:D000756 | Anemia, Sideroblastic | Iron | 4.30 | 16910769 | |
MESH:D000799 | Angioedema | Acetaminophen | 3.27 | 10982225 | |
MESH:D001008 | Anxiety Disorders | Valproic Acid | 7.35 | 17497229 | |
MESH:D001008 | Anxiety Disorders | vinclozolin | 7.35 | 19015723 | |
MESH:D001014 | Aortic Aneurysm | Indomethacin | 4.31 | 10231640 | |
MESH:D017544 | Aortic Aneurysm, Abdominal | Indomethacin | 4.32 | 10388637 | |
MESH:D001145 | Arrhythmias, Cardiac | Iron | 3.88 | 16604332 | |
MESH:D020261 | Arsenic Poisoning | Arsenic | 2.68 | 16835338 12569548 16251483 18414634 | |
MESH:D001161 | Arteriosclerosis | Dietary Fats | 3.34 | 15238619 | |
MESH:D018771 | Arthralgia | Indomethacin | 4.59 | 2160914 | |
MESH:D001169 | Arthritis, Experimental | Tosylphenylalanyl Chloromethyl Ketone | 6.76 | 18706406 | |
MESH:D001169 | Arthritis, Experimental | Tretinoin | 6.76 | 16412693 | |
MESH:D001172 | Arthritis, Rheumatoid | Indomethacin | 6.47 | 11248219 | |
MESH:D001172 | Arthritis, Rheumatoid | Ozone | 6.47 | 15570426 | |
MESH:D001172 | Arthritis, Rheumatoid | Tretinoin | 6.47 | 16292516 | |
MESH:D001249 | Asthma | Ozone | 6.86 | 17854713 16373670 | |
MESH:D001249 | Asthma | Tretinoin | 6.86 | 16456186 | |
MESH:D001249 | Asthma | zileuton | 6.86 | 17944539 8598621 19214143 10764316 10181070 20332717 9620945 | |
MESH:D001250 | Asthma, Exercise-Induced | zileuton | 5.03 | 10984370 | |
MESH:D001260 | Ataxia Telangiectasia | Iron | 4.88 | 15336622 | |
MESH:D050197 | Atherosclerosis | Arsenic | 5.86 | 19371607 12928151 | |
MESH:D050197 | Atherosclerosis | Iron | 5.86 | 16632123 16640825 | |
MESH:D001321 | Autistic Disorder | Acetaminophen | 2.48 | 18445737 | |
MESH:D001321 | Autistic Disorder | Glutathione | 2.48 | 19056591 16917939 18929414 19267885 | |
MESH:D001321 | Autistic Disorder | Iron | 2.48 | 17352947 | |
MESH:D001321 | Autistic Disorder | Valproic Acid | 2.48 | 18558336 17688650 17507914 18775368 18985861 18940202 15238991 16609825 18316065 18396377 20603192 17157402 19460635 18177632 19232924 | |
MESH:D001327 | Autoimmune Diseases | Cholecalciferol | 4.48 | 16142846 | |
MESH:D001424 | Bacterial Infections | Iron | 4.63 | 16640825 | |
MESH:D001471 | Barrett Esophagus | Tretinoin | 3.86 | 16935849 | |
MESH:D001477 | Bartter Syndrome | Indomethacin | 4.43 | 10684365 | |
MESH:D001714 | Bipolar Disorder | Valproic Acid | 2.76 | 20046352 17594078 | |
MESH:D001778 | Blood Coagulation Disorders | arsenic trioxide | 7.48 | 16206674 | |
MESH:D001778 | Blood Coagulation Disorders | Tretinoin | 7.48 | 16197459 16206674 | |
MESH:D001848 | Bone Diseases, Developmental | Valproic Acid | 3.02 | 8888407 | |
MESH:D001859 | Bone Neoplasms | Paclitaxel | 4.04 | 15867366 | |
MESH:D001929 | Brain Edema | Indomethacin | 10.96 | 11481608 | |
MESH:D001929 | Brain Edema | zileuton | 10.96 | 19309543 | |
MESH:D002545 | Brain Ischemia | Indomethacin | 3.86 | 12524144 | |
MESH:D001943 | Breast Neoplasms | alitretinoin | 4.11 | 16344269 | |
MESH:D001943 | Breast Neoplasms | Calcitriol | 4.11 | 11237771 | |
MESH:D001943 | Breast Neoplasms | decitabine | 4.11 | 19208741 18320071 | |
MESH:D001943 | Breast Neoplasms | Dietary Fats | 4.11 | 20435547 | |
MESH:D001943 | Breast Neoplasms | Indomethacin | 4.11 | 17401462 | |
MESH:D001943 | Breast Neoplasms | Paclitaxel | 4.11 | 16273361 11325840 15136595 18223236 16244791 16115903 18323546 18234424 | |
MESH:D001943 | Breast Neoplasms | tanshinone | 4.11 | 15849732 19885617 | |
MESH:D001943 | Breast Neoplasms | Tretinoin | 4.11 | 16443354 16873071 16166294 | |
MESH:D016535 | Bronchial Hyperreactivity | Ozone | 7.51 | 18315731 16777450 18417511 14754758 15516495 19059883 17626835 | |
MESH:D016535 | Bronchial Hyperreactivity | zileuton | 7.51 | 12654629 12794006 12388339 | |
MESH:D001997 | Bronchopulmonary Dysplasia | Tretinoin | 4.02 | 16813970 | |
MESH:D002051 | Burkitt Lymphoma | arsenic trioxide | 3.81 | 11589617 | |
MESH:D002056 | Burns | Indomethacin | 4.15 | 10459503 | |
MESH:D002100 | Cachexia | Indomethacin | 10.52 | 15141370 16537180 11239499 15625704 | |
MESH:D002100 | Cachexia | Ozone | 10.52 | 16183385 | |
MESH:D002280 | Carcinoma, Basal Cell | Arsenic | 3.25 | 17687452 15504454 | |
MESH:D018236 | Carcinoma, Embryonal | Tretinoin | 4.58 | 16168501 | |
MESH:D006528 | Carcinoma, Hepatocellular | Acetaminophen | 12.19 | 3084413 | |
MESH:D006528 | Carcinoma, Hepatocellular | Arsenic | 12.19 | 17306315 16507464 | |
MESH:D006528 | Carcinoma, Hepatocellular | arsenic trioxide | 12.19 | 15553829 14691202 11135700 15073043 16217749 | |
MESH:D006528 | Carcinoma, Hepatocellular | Indomethacin | 12.19 | 16391822 | |
MESH:D006528 | Carcinoma, Hepatocellular | Paclitaxel | 12.19 | 16313753 | |
MESH:D006528 | Carcinoma, Hepatocellular | Phenobarbital | 12.19 | 6705139 17173139 20007298 20935162 1701930 | |
MESH:D006528 | Carcinoma, Hepatocellular | Tretinoin | 12.19 | 1917145 | |
MESH:D018827 | Carcinoma, Lewis Lung | Indomethacin | 4.16 | 11053908 | |
MESH:D018276 | Carcinoma, Medullary | Indomethacin | 4.78 | 14736730 11352223 18791128 | |
MESH:D002291 | Carcinoma, Papillary | arsenic trioxide | 4.30 | 19014326 | |
MESH:D002292 | Carcinoma, Renal Cell | Indomethacin | 3.08 | 17341418 | |
MESH:D018288 | Carcinoma, Small Cell | arsenic trioxide | 3.62 | 12490120 | |
MESH:D002294 | Carcinoma, Squamous Cell | Arsenic | 18.88 | 18922899 17687452 15504454 | |
MESH:D002294 | Carcinoma, Squamous Cell | Calcitriol | 18.88 | 11237771 | |
MESH:D002294 | Carcinoma, Squamous Cell | decitabine | 18.88 | 19215824 | |
MESH:D002294 | Carcinoma, Squamous Cell | Glutathione | 18.88 | 17015178 | |
MESH:D002294 | Carcinoma, Squamous Cell | Indomethacin | 18.88 | 12636206 15482327 | |
MESH:D002294 | Carcinoma, Squamous Cell | Tetradecanoylphorbol Acetate | 18.88 | 18922899 | |
MESH:D002294 | Carcinoma, Squamous Cell | Tretinoin | 18.88 | 16096774 16051514 | |
MESH:D002295 | Carcinoma, Transitional Cell | Arsenic | 3.58 | 18640142 | |
MESH:D009202 | Cardiomyopathies | Iron | 3.66 | 16640825 | |
MESH:D002311 | Cardiomyopathy, Dilated | Iron | 3.24 | 16604332 | |
MESH:D002318 | Cardiovascular Diseases | Arsenic | 6.23 | 15738583 17938729 19152805 | |
MESH:D002318 | Cardiovascular Diseases | Hydrogen Peroxide | 6.23 | 16936243 | |
MESH:D002340 | Carotid Artery Diseases | Arsenic | 3.83 | 18022660 16973168 | |
MESH:D002386 | Cataract | Acetaminophen | 6.04 | 10977129 | |
MESH:D002386 | Cataract | Tretinoin | 6.04 | 17460283 | |
MESH:D002493 | Central Nervous System Diseases | Phenobarbital | 3.70 | 4080065 | |
MESH:D018290 | Cervical Intraepithelial Neoplasia | Tretinoin | 4.02 | 16129372 | |
MESH:D002659 | Child Development Disorders, Pervasive | Valproic Acid | 2.48 | 20734317 | |
MESH:D002761 | Cholangitis | 1-Naphthylisothiocyanate | 5.62 | 12912871 | |
MESH:D002764 | Cholecystitis | Indomethacin | 4.59 | 11181007 | |
MESH:D002779 | Cholestasis | 1-Naphthylisothiocyanate | 3.90 | 19486331 18590720 15913567 7624871 15500046 16629650 18164287 12927374 | |
MESH:D002780 | Cholestasis, Intrahepatic | 1-Naphthylisothiocyanate | 5.28 | 19407337 10220858 | |
MESH:D002822 | Choriocarcinoma | Tretinoin | 4.58 | 16461808 | |
MESH:D002972 | Cleft Palate | Tretinoin | 2.41 | 9407595 | |
MESH:D003092 | Colitis | Tretinoin | 3.16 | 17035595 | |
MESH:D003110 | Colonic Neoplasms | decitabine | 7.26 | 17616700 | |
MESH:D003110 | Colonic Neoplasms | Indomethacin | 7.26 | 15963497 15936596 15637740 11260862 15625704 15786552 | |
MESH:D003110 | Colonic Neoplasms | Iron | 7.26 | 16640825 | |
MESH:D003110 | Colonic Neoplasms | zileuton | 7.26 | 18927292 | |
MESH:D015179 | Colorectal Neoplasms | arsenic trioxide | 4.24 | 20501625 | |
MESH:D015179 | Colorectal Neoplasms | decitabine | 4.24 | 18981723 | |
MESH:D015179 | Colorectal Neoplasms | Indomethacin | 4.24 | 11197048 12606626 17054584 18059344 | |
MESH:D015179 | Colorectal Neoplasms | Paclitaxel | 4.24 | 18802399 | |
MESH:D023903 | Coronary Restenosis | arsenic trioxide | 3.65 | 12609071 | |
MESH:D018352 | Coronavirus Infections | Indomethacin | 5.14 | 17302372 | |
MESH:D019465 | Craniofacial Abnormalities | arsenic trioxide | 3.39 | 10525206 | |
MESH:D019465 | Craniofacial Abnormalities | Tretinoin | 3.39 | 9142499 17551590 14991402 10589399 9224671 16925845 9664655 9211117 9125849 8800419 | |
MESH:D019465 | Craniofacial Abnormalities | Valproic Acid | 3.39 | 8888407 17688650 16575769 | |
MESH:D003456 | Cryptorchidism | vinclozolin | 3.80 | 14966744 | |
MESH:D003550 | Cystic Fibrosis | Glutathione | 4.00 | 19747007 | |
MESH:D016757 | Death, Sudden, Cardiac | arsenic trioxide | 3.57 | 15213294 | |
MESH:D003665 | Decompression Sickness | zileuton | 5.65 | 18309904 | |
MESH:D003920 | Diabetes Mellitus | Iron | 3.97 | 16640825 16604332 | |
MESH:D003922 | Diabetes Mellitus, Type 1 | Iron | 3.16 | 16506275 | |
MESH:D003924 | Diabetes Mellitus, Type 2 | Iron | 2.94 | 16506275 | |
MESH:D003967 | Diarrhea | Indomethacin | 3.27 | 7907874 7237001 | |
MESH:D056486 | Drug-Induced Liver Injury | 1-Naphthylisothiocyanate | 7.41 | 17522070 20133375 7624871 18289764 | |
MESH:D056486 | Drug-Induced Liver Injury | Acetaminophen | 7.41 | 12958197 11529661 17906064 11743745 10915739 11739529 14725611 14550746 11834606 2444490 17522070 19923254 16109766 19370779 12540782 16393943 11461765 10774834 19739265 15619225 16177239 18713872 16781746 16485898 16227642 12594235 14986274 10663392 11287661 17562736 19416960 12392966 19085960 12153990 15968718 19164858 16081117 19420014 18071297 11421492 12705907 | |
MESH:D056486 | Drug-Induced Liver Injury | Valproic Acid | 7.41 | 19641884 1733752 | |
MESH:D056486 | Drug-Induced Liver Injury | zileuton | 7.41 | 17944539 | |
MESH:D056487 | Drug-Induced Liver Injury, Chronic | Acetaminophen | 3.52 | 19426721 | |
MESH:D004374 | Ductus Arteriosus, Patent | Indomethacin | 4.58 | 18446180 17190690 18043480 16133044 16326151 12774134 | |
MESH:D004381 | Duodenal Ulcer | Indomethacin | 3.60 | 11535926 16699067 17045617 11595415 17151854 11991626 17329845 17351913 10671773 17202747 11595431 | |
MESH:D050171 | Dyslipidemias | Dietary Fats | 3.03 | 18367378 | |
MESH:D004421 | Dystonia | Phenobarbital | 8.70 | 1851702 | |
MESH:D004421 | Dystonia | Valproic Acid | 8.70 | 1851702 | |
MESH:D004487 | Edema | Indomethacin | 8.98 | 10653021 16100529 8985016 7907874 19703484 7990266 8273558 | |
MESH:D004487 | Edema | Tetradecanoylphorbol Acetate | 8.98 | 7812673 15177302 8113982 11698051 9599246 16716910 8273558 | |
MESH:D004487 | Edema | zileuton | 8.98 | 9831321 8273558 11698051 19703484 17118201 7990266 7812673 | |
MESH:D004489 | Edema, Cardiac | Tretinoin | 3.89 | 18230668 | |
MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Calcitriol | 3.40 | 15138306 | |
MESH:D004701 | Endocrine Gland Neoplasms | decitabine | 4.54 | 19294695 | |
MESH:D018159 | Endolymphatic Hydrops | Dimethyl Sulfoxide | 5.98 | 20641076 | |
MESH:D016889 | Endometrial Neoplasms | Tretinoin | 2.72 | 16569247 | |
MESH:D004715 | Endometriosis | Indomethacin | 3.65 | 15652904 | |
MESH:D019446 | Endotoxemia | Indomethacin | 14.48 | 18509659 | |
MESH:D019446 | Endotoxemia | Lipopolysaccharides | 14.48 | 17637181 15821434 15328337 | |
MESH:D019446 | Endotoxemia | zileuton | 14.48 | 15328337 | |
MESH:D004751 | Enteritis | Indomethacin | 4.17 | 17763956 10567023 16328016 | |
MESH:D020345 | Enterocolitis, Necrotizing | Indomethacin | 4.43 | 17980183 | |
MESH:D004802 | Eosinophilia | Indomethacin | 7.67 | 11298111 | |
MESH:D004802 | Eosinophilia | zileuton | 7.67 | 8621850 10764316 | |
MESH:D004831 | Epilepsies, Myoclonic | Phenobarbital | 8.96 | 3659116 | |
MESH:D004831 | Epilepsies, Myoclonic | Valproic Acid | 8.96 | 17275665 3659116 | |
MESH:D004828 | Epilepsies, Partial | Phenobarbital | 8.06 | 3922381 11558140 | |
MESH:D004828 | Epilepsies, Partial | Valproic Acid | 8.06 | 3922381 16628512 | |
MESH:D004827 | Epilepsy | Phenobarbital | 5.60 | 20417680 | |
MESH:D004827 | Epilepsy | Valproic Acid | 5.60 | 18234410 20417680 | |
MESH:D004832 | Epilepsy, Absence | Phenobarbital | 7.27 | 6401628 | |
MESH:D004832 | Epilepsy, Absence | Valproic Acid | 7.27 | 7562514 6426943 6254150 | |
MESH:D017029 | Epilepsy, Complex Partial | Phenobarbital | 9.47 | 7750514 | |
MESH:D017029 | Epilepsy, Complex Partial | Valproic Acid | 9.47 | 7750514 | |
MESH:D004830 | Epilepsy, Tonic-Clonic | Phenobarbital | 8.60 | 3659116 | |
MESH:D004830 | Epilepsy, Tonic-Clonic | Valproic Acid | 8.60 | 3659116 | |
MESH:D004938 | Esophageal Neoplasms | arsenic trioxide | 6.36 | 12903497 | |
MESH:D004938 | Esophageal Neoplasms | Indomethacin | 6.36 | 11005569 | |
MESH:D004938 | Esophageal Neoplasms | Paclitaxel | 6.36 | 16481741 | |
MESH:D005124 | Eye Abnormalities | Tretinoin | 3.15 | 9664655 16938888 | |
MESH:D005234 | Fatty Liver | arsenic trioxide | 14.71 | 15073043 | |
MESH:D005234 | Fatty Liver | Dietary Fats | 14.71 | 19551842 17967931 18296743 19004024 | |
MESH:D005234 | Fatty Liver | Iron | 14.71 | 16640825 | |
MESH:D005234 | Fatty Liver | Valproic Acid | 14.71 | 14986274 19224547 | |
MESH:D005315 | Fetal Diseases | Valproic Acid | 4.31 | 16575769 | |
MESH:D005317 | Fetal Growth Retardation | Valproic Acid | 3.59 | 8888407 18558336 | |
MESH:D005334 | Fever | Indomethacin | 7.72 | 11852909 17627676 10431976 | |
MESH:D005334 | Fever | Lipopolysaccharides | 7.72 | 9205823 11852909 | |
MESH:D005354 | Fibrosarcoma | Indomethacin | 4.33 | 10962813 | |
MESH:D005355 | Fibrosis | Dietary Fats | 11.74 | 18296743 | |
MESH:D005355 | Fibrosis | Indomethacin | 11.74 | 17994277 | |
MESH:D005355 | Fibrosis | Tretinoin | 11.74 | 17994277 | |
MESH:D005499 | Folliculitis | Indomethacin | 4.59 | 11298111 | |
MESH:D005534 | Foot Diseases | Arsenic | 4.98 | 6392382 | |
MESH:D005596 | Fractures, Closed | zileuton | 5.29 | 19544365 | |
MESH:D005621 | Friedreich Ataxia | Iron | 4.87 | 16604332 16640825 | |
MESH:D005706 | Gallbladder Neoplasms | arsenic trioxide | 3.72 | 16904648 | |
MESH:D005756 | Gastritis | Acetaminophen | 9.23 | 16983495 | |
MESH:D005756 | Gastritis | Indomethacin | 9.23 | 15046732 | |
MESH:D030342 | Genetic Diseases, Inborn | vinclozolin | 4.37 | 16973722 | |
MESH:D005832 | Genital Diseases, Male | vinclozolin | 4.72 | 16417039 | |
MESH:D005909 | Glioblastoma | Indomethacin | 6.04 | 12870263 | |
MESH:D005909 | Glioblastoma | Tretinoin | 6.04 | 17312396 | |
MESH:D005910 | Glioma | Indomethacin | 5.82 | 16487511 18371953 | |
MESH:D005910 | Glioma | tanshinone | 5.82 | 16955220 | |
MESH:D005923 | Glomerulosclerosis, Focal Segmental | Indomethacin | 3.83 | 11849393 | |
MESH:D006073 | Gout | Indomethacin | 4.78 | 11248219 | |
MESH:D006258 | Head and Neck Neoplasms | decitabine | 10.72 | 19215824 | |
MESH:D006258 | Head and Neck Neoplasms | Indomethacin | 10.72 | 15482327 | |
MESH:D006258 | Head and Neck Neoplasms | Tretinoin | 10.72 | 16096774 | |
MESH:D034381 | Hearing Loss | Dimethyl Sulfoxide | 4.69 | 20641076 | |
MESH:D006317 | Hearing Loss, Noise-Induced | Tretinoin | 4.58 | 16084493 | |
MESH:D006330 | Heart Defects, Congenital | Tretinoin | 2.58 | 14991402 9664655 | |
MESH:D006432 | Hemochromatosis | Iron | 4.07 | 17053826 16640825 17236123 16574947 16604332 17255318 | |
MESH:D006463 | Hemolytic-Uremic Syndrome | Lipopolysaccharides | 3.89 | 16366002 | |
MESH:D006486 | Hemosiderosis | Iron | 4.64 | 16604332 | |
MESH:D006501 | Hepatic Encephalopathy | Indomethacin | 4.06 | 15633222 | |
MESH:D006505 | Hepatitis | 1-Naphthylisothiocyanate | 4.16 | 18590720 | |
MESH:D019698 | Hepatitis C, Chronic | Indomethacin | 4.14 | 15135802 | |
MESH:D006525 | Hepatitis, Viral, Human | Iron | 4.89 | 16640825 | |
MESH:D006527 | Hepatolenticular Degeneration | Iron | 4.39 | 17182432 | |
MESH:D006529 | Hepatomegaly | Iron | 11.65 | 16890145 | |
MESH:D006529 | Hepatomegaly | Phenobarbital | 11.65 | 16109766 | |
MESH:D006529 | Hepatomegaly | zileuton | 11.65 | 8661344 | |
MESH:D015658 | HIV Infections | Iron | 3.35 | 16597321 | |
MESH:D006849 | Hydrocephalus | Valproic Acid | 4.30 | 17688650 | |
MESH:D006930 | Hyperalgesia | Acetaminophen | 10.46 | 16870215 | |
MESH:D006930 | Hyperalgesia | Indomethacin | 10.46 | 12727271 | |
MESH:D006930 | Hyperalgesia | Tretinoin | 10.46 | 16870215 | |
MESH:D034321 | Hyperamylasemia | Indomethacin | 5.14 | 17883296 | |
MESH:D006937 | Hypercholesterolemia | Dietary Fats | 3.09 | 21332399 | |
MESH:D006940 | Hyperemia | Indomethacin | 4.44 | 12524144 | |
MESH:D017681 | Hypereosinophilic Syndrome | Tretinoin | 4.01 | 16778211 | |
MESH:D017488 | Hyperkeratosis, Epidermolytic | Arsenic | 3.96 | 17050553 | |
MESH:D006949 | Hyperlipidemias | Dietary Fats | 7.61 | 21332399 | |
MESH:D006949 | Hyperlipidemias | Indomethacin | 7.61 | 17546600 | |
MESH:D006973 | Hypertension | Arsenic | 2.64 | 16076760 11953799 9931084 | |
MESH:D046110 | Hypertension, Pregnancy-Induced | Hydralazine | 4.07 | 16612254 | |
MESH:D006976 | Hypertension, Pulmonary | zileuton | 4.25 | 14726295 | |
MESH:D017379 | Hypertrophy, Left Ventricular | tanshinone | 4.74 | 19662366 | |
MESH:D006987 | Hypesthesia | Arsenic | 4.98 | 16093927 | |
MESH:D007006 | Hypogonadism | Iron | 3.99 | 16640825 | |
MESH:D007037 | Hypothyroidism | Iron | 4.53 | 16640825 | |
MESH:D007077 | Ileal Diseases | Indomethacin | 4.45 | 10574470 18306037 | |
MESH:D007079 | Ileitis | marker/mechanism | 10647630 | ||
MESH:D007079 | Ileitis | Indomethacin | 4.78 | 10651667 10647630 16133968 | |
MESH:D007235 | Infant, Premature, Diseases | Indomethacin | 4.79 | 16133044 | |
MESH:D020244 | Infarction, Middle Cerebral Artery | zileuton | 5.08 | 19309543 | |
MESH:D007248 | Infertility, Male | decitabine | 5.62 | 17581917 | |
MESH:D007248 | Infertility, Male | vinclozolin | 5.62 | 16467254 | |
MESH:D007249 | Inflammation | Dietary Fats | 15.79 | 20412841 | |
MESH:D007249 | Inflammation | Flavonoids | 15.79 | 17296493 | |
MESH:D007249 | Inflammation | Indomethacin | 15.79 | 12568917 3291741 7812673 | |
MESH:D007249 | Inflammation | Lipopolysaccharides | 15.79 | 17237260 9205823 12878042 17963957 17255318 | |
MESH:D007249 | Inflammation | Tetradecanoylphorbol Acetate | 15.79 | 15177302 8273558 7562506 7812673 11698051 | |
MESH:D007249 | Inflammation | zileuton | 15.79 | 9831321 17118201 18309904 7812673 18059327 18295198 8960868 8621850 | |
MESH:D015212 | Inflammatory Bowel Diseases | zileuton | 3.90 | 15339030 | |
MESH:D007333 | Insulin Resistance | Dietary Fats | 2.72 | 18457598 11836018 | |
MESH:D007410 | Intestinal Diseases | Indomethacin | 8.06 | 17329856 17994277 11713966 15610444 18236018 11855677 15831440 11686837 10210152 | |
MESH:D007410 | Intestinal Diseases | Tretinoin | 8.06 | 17994277 | |
MESH:D007414 | Intestinal Neoplasms | caffeic acid phenethyl ester | 4.09 | 10783313 | |
MESH:D019586 | Intracranial Hypertension | Indomethacin | 4.79 | 15241188 | |
MESH:D019189 | Iron Metabolism Disorders | Iron | 9.85 | 17163184 | |
MESH:D019189 | Iron Metabolism Disorders | Lipopolysaccharides | 9.85 | 17255318 | |
MESH:D007569 | Jaw Abnormalities | Tretinoin | 3.39 | 17551590 15992940 | |
MESH:D007579 | Jejunal Diseases | Indomethacin | 4.45 | 18306037 10574470 16133968 | |
MESH:D007642 | Keratosis | Arsenic | 4.42 | 16930632 12749816 | |
MESH:D017492 | Keratosis, Seborrheic | alitretinoin | 5.07 | 16144296 | |
MESH:D007674 | Kidney Diseases | Acetaminophen | 8.20 | 15629191 12587719 | |
MESH:D007674 | Kidney Diseases | caffeic acid phenethyl ester | 8.20 | 15369732 | |
MESH:D007674 | Kidney Diseases | Indomethacin | 8.20 | 17190690 | |
MESH:D007676 | Kidney Failure, Chronic | Hydrogen Peroxide | 3.77 | 16518626 | |
MESH:D016773 | Leishmaniasis, Cutaneous | Indomethacin | 3.44 | 11703811 12228301 10320625 | |
MESH:D007938 | Leukemia | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 12.44 | 12970779 | |
MESH:D007938 | Leukemia | arsenic trioxide | 12.44 | 15070760 | |
MESH:D007938 | Leukemia | decitabine | 12.44 | 18980019 19235587 | |
MESH:D007938 | Leukemia | Tretinoin | 12.44 | 17143497 | |
MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | arsenic trioxide | 3.29 | 17077332 12560223 | |
MESH:D007948 | Leukemia, Monocytic, Acute | arsenic trioxide | 16.40 | 16972261 | |
MESH:D007948 | Leukemia, Monocytic, Acute | PD 98059 | 16.40 | 16972261 | |
MESH:D007948 | Leukemia, Monocytic, Acute | U 0126 | 16.40 | 16972261 | |
MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | arsenic disulfide | 16.60 | 12421474 | |
MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | arsenic trioxide | 16.60 | 14633726 | |
MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Indomethacin | 16.60 | 10785260 15631656 16572323 | |
MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | zileuton | 16.60 | 19503090 19823023 | |
MESH:D007951 | Leukemia, Myeloid | arsenic trioxide | 13.07 | 19077051 | |
MESH:D007951 | Leukemia, Myeloid | decitabine | 13.07 | 18454857 19117987 17236224 | |
MESH:D007951 | Leukemia, Myeloid | Tretinoin | 13.07 | 16932348 16482212 19285840 | |
MESH:D015470 | Leukemia, Myeloid, Acute | 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide | 16.02 | 16467208 17077328 | |
MESH:D015470 | Leukemia, Myeloid, Acute | arsenic trioxide | 16.02 | 16467208 16968895 20471514 19850784 17050201 | |
MESH:D015470 | Leukemia, Myeloid, Acute | decitabine | 16.02 | 18460780 19387464 17679729 18206229 19010910 18704418 | |
MESH:D015470 | Leukemia, Myeloid, Acute | Indomethacin | 16.02 | 18360721 | |
MESH:D015470 | Leukemia, Myeloid, Acute | Tretinoin | 16.02 | 16294345 17596541 19850784 | |
MESH:D015470 | Leukemia, Myeloid, Acute | Valproic Acid | 16.02 | 16294345 17596541 | |
MESH:D015470 | Leukemia, Myeloid, Acute | Vitamin D | 16.02 | 20368581 | |
MESH:D015477 | Leukemia, Myelomonocytic, Chronic | decitabine | 4.88 | 18055864 | |
MESH:D015473 | Leukemia, Promyelocytic, Acute | marker/mechanism | 16764927 | ||
MESH:D015473 | Leukemia, Promyelocytic, Acute | 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide | 19.78 | 17077328 | |
MESH:D015473 | Leukemia, Promyelocytic, Acute | Arsenic | 19.78 | 17339181 | |
MESH:D015473 | Leukemia, Promyelocytic, Acute | arsenic trioxide | 19.78 | 19642359 12018890 11468182 17869043 17712046 15336539 12712474 15622746 19035177 16331271 16823087 15748426 19075265 16330433 15213294 17217047 16112521 12679006 9834237 11161223 16966277 19225113 17649720 16891316 17107899 | |
MESH:D015473 | Leukemia, Promyelocytic, Acute | caffeic acid phenethyl ester | 19.78 | 16766008 | |
MESH:D015473 | Leukemia, Promyelocytic, Acute | Tretinoin | 19.78 | 9834237 16766008 17712046 17368321 17361223 17217047 17649720 16140955 19075265 16935935 16788101 17301526 12679006 15748426 17506722 16331271 16891316 19225113 16823087 19029980 17339181 19642359 17294898 19035177 17107899 | |
MESH:D015458 | Leukemia, T-Cell | arsenic trioxide | 3.81 | 16882451 | |
MESH:D007964 | Leukocytosis | Indomethacin | 4.79 | 16537180 | |
MESH:D007969 | Leukomalacia, Periventricular | Indomethacin | 5.14 | 17980183 | |
MESH:D007970 | Leukopenia | Lipopolysaccharides | 4.13 | 15821434 | |
MESH:D020961 | Lewy Body Disease | Iron | 4.87 | 16563566 | |
MESH:D007984 | Leydig Cell Tumor | vinclozolin | 4.17 | 16417039 | |
MESH:D017880 | Limb Deformities, Congenital | Tretinoin | 2.89 | 9224671 | |
MESH:D008080 | Liposarcoma | Paclitaxel | 4.30 | 17353645 | |
MESH:D008101 | Liver Abscess, Amebic | Indomethacin | 5.14 | 11479899 | |
MESH:D008103 | Liver Cirrhosis | Dietary Fats | 9.19 | 18296743 | |
MESH:D008103 | Liver Cirrhosis | Iron | 9.19 | 16640825 | |
MESH:D008103 | Liver Cirrhosis | Phenobarbital | 9.19 | 21047994 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Dimethyl Sulfoxide | 4.35 | 11682029 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Indomethacin | 4.35 | 18194892 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Lipopolysaccharides | 4.35 | 12878042 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Tretinoin | 4.35 | 16248980 18397230 | |
MESH:D008107 | Liver Diseases | 1-Naphthylisothiocyanate | 7.91 | 17184895 | |
MESH:D008107 | Liver Diseases | Acetaminophen | 7.91 | 12587719 19460945 11587558 19014921 16610002 12969438 16611625 19784758 | |
MESH:D008107 | Liver Diseases | Arsenic | 7.91 | 11134558 | |
MESH:D008107 | Liver Diseases | Phenobarbital | 7.91 | 19363144 | |
MESH:D008108 | Liver Diseases, Alcoholic | Iron | 4.45 | 17207112 16737972 | |
MESH:D017114 | Liver Failure, Acute | Acetaminophen | 2.74 | 16871587 17185352 | |
MESH:D008113 | Liver Neoplasms | Arsenic | 8.73 | 16368122 | |
MESH:D008113 | Liver Neoplasms | arsenic trioxide | 8.73 | 14682389 | |
MESH:D008113 | Liver Neoplasms | Iron | 8.73 | 16640825 20302851 | |
MESH:D008113 | Liver Neoplasms | Phenobarbital | 8.73 | 19812893 15975961 19073162 21047994 8742319 19482888 | |
MESH:D008114 | Liver Neoplasms, Experimental | arsenic trioxide | 4.80 | 20377131 | |
MESH:D008114 | Liver Neoplasms, Experimental | Phenobarbital | 4.80 | 1399818 6150874 17172636 2563599 18308698 | |
MESH:D008133 | Long QT Syndrome | arsenic trioxide | 2.91 | 15213294 | |
MESH:D008171 | Lung Diseases | Ozone | 2.99 | 19066396 8266340 | |
MESH:D017563 | Lung Diseases, Interstitial | Valproic Acid | 3.69 | 17228818 | |
MESH:D055370 | Lung Injury | Lipopolysaccharides | 7.42 | 21114838 | |
MESH:D055370 | Lung Injury | Ozone | 7.42 | 20417186 | |
MESH:D008175 | Lung Neoplasms | alitretinoin | 9.24 | 16413115 | |
MESH:D008175 | Lung Neoplasms | Arsenic | 9.24 | 19168569 17306315 17976673 | |
MESH:D008175 | Lung Neoplasms | arsenic trioxide | 9.24 | 11798837 19825857 | |
MESH:D008175 | Lung Neoplasms | Indomethacin | 9.24 | 11497255 16537180 11053908 | |
MESH:D008175 | Lung Neoplasms | Iron | 9.24 | 16640825 | |
MESH:D008175 | Lung Neoplasms | Ozone | 9.24 | 7614698 8597069 | |
MESH:D008175 | Lung Neoplasms | Tetradecanoylphorbol Acetate | 9.24 | 11807781 | |
MESH:D008180 | Lupus Erythematosus, Systemic | marker/mechanism | 18204446 18204448 | ||
MESH:D008223 | Lymphoma | decitabine | 3.01 | 19470736 | |
MESH:D008228 | Lymphoma, Non-Hodgkin | Paclitaxel | 3.63 | 14749477 | |
MESH:D008268 | Macular Degeneration | Iron | 3.65 | 16640825 | |
MESH:D008325 | Mammary Neoplasms, Experimental | Tetradecanoylphorbol Acetate | 3.00 | 8985016 | |
MESH:D008527 | Medulloblastoma | Tretinoin | 2.53 | 17453147 | |
MESH:D008545 | Melanoma | decitabine | 4.46 | 16505122 17785578 | |
MESH:D008545 | Melanoma | Paclitaxel | 4.46 | 12025231 12040289 16342250 | |
MESH:D008545 | Melanoma | Tretinoin | 4.46 | 16752155 | |
MESH:D008546 | Melanoma, Experimental | Acetaminophen | 3.02 | 19513568 | |
MESH:D008591 | Meningomyelocele | Tretinoin | 3.87 | 16940565 | |
MESH:D008679 | Metaplasia | Ozone | 4.53 | 10496685 | |
MESH:D008881 | Migraine Disorders | Indomethacin | 6.34 | 11903285 | |
MESH:D008881 | Migraine Disorders | Valproic Acid | 6.34 | 18803445 18765137 | |
MESH:D009062 | Mouth Neoplasms | Indomethacin | 3.55 | 12636206 | |
MESH:D009101 | Multiple Myeloma | arsenic trioxide | 9.80 | 19417148 14977855 19549372 15949261 11468182 | |
MESH:D009101 | Multiple Myeloma | decitabine | 9.80 | 18172295 | |
MESH:D009101 | Multiple Myeloma | Paclitaxel | 9.80 | 14749477 | |
MESH:D020528 | Multiple Sclerosis, Chronic Progressive | Iron | 5.09 | 17086897 | |
MESH:D009139 | Musculoskeletal Abnormalities | Valproic Acid | 3.52 | 8888407 | |
MESH:D009181 | Mycoses | Iron | 4.89 | 16640825 | |
MESH:D009182 | Mycosis Fungoides | arsenic trioxide | 4.09 | 18349030 | |
MESH:D009190 | Myelodysplastic Syndromes | arsenic trioxide | 14.71 | 16882451 16105982 | |
MESH:D009190 | Myelodysplastic Syndromes | decitabine | 14.71 | 19010910 18608210 19157545 16882708 | |
MESH:D009190 | Myelodysplastic Syndromes | Tretinoin | 14.71 | 17596541 | |
MESH:D009190 | Myelodysplastic Syndromes | Valproic Acid | 14.71 | 17596541 | |
MESH:D017202 | Myocardial Ischemia | Arsenic | 8.01 | 15371236 | |
MESH:D017202 | Myocardial Ischemia | Iron | 8.01 | 16604332 | |
MESH:D015428 | Myocardial Reperfusion Injury | Iron | 3.83 | 16604332 | |
MESH:D020191 | Myoclonic Epilepsies, Progressive | Phenobarbital | 3.91 | 17484760 | |
MESH:D009298 | Nasal Polyps | zileuton | 5.65 | 10665187 | |
MESH:D009361 | Neoplasm Invasiveness | arsenic trioxide | 3.42 | 16624393 | |
MESH:D009362 | Neoplasm Metastasis | Indomethacin | 5.34 | 16537180 11239499 11053908 | |
MESH:D009362 | Neoplasm Metastasis | Paclitaxel | 5.34 | 15867366 | |
MESH:D009369 | Neoplasms | alitretinoin | 6.65 | 16946489 | |
MESH:D009369 | Neoplasms | decitabine | 6.65 | 19116145 17925555 19470736 | |
MESH:D009369 | Neoplasms | Tretinoin | 6.65 | 16594593 16946489 | |
MESH:D009374 | Neoplasms, Experimental | Indomethacin | 3.59 | 10663608 15625704 | |
MESH:D009404 | Nephrotic Syndrome | Iron | 4.04 | 17178036 | |
MESH:D009421 | Nervous System Malformations | Tretinoin | 3.24 | 9125849 | |
MESH:D009436 | Neural Tube Defects | Arsenic | 14.17 | 16620997 | |
MESH:D009436 | Neural Tube Defects | arsenic trioxide | 14.17 | 10525206 | |
MESH:D009436 | Neural Tube Defects | Tretinoin | 14.17 | 9142499 | |
MESH:D009436 | Neural Tube Defects | Valproic Acid | 14.17 | 16359493 8888407 | |
MESH:D019636 | Neurodegenerative Diseases | Acetaminophen | 11.50 | 18514411 | |
MESH:D019636 | Neurodegenerative Diseases | Indomethacin | 11.50 | 12349958 | |
MESH:D019636 | Neurodegenerative Diseases | Iron | 11.50 | 17296847 16604332 | |
MESH:D020078 | Neurogenic Inflammation | Arsenic | 3.85 | 17056641 | |
MESH:D009765 | Obesity | Dietary Fats | 2.13 | 20132043 17217161 18674790 21332399 16723640 11836018 19632207 18457598 20518802 | |
MESH:D007752 | Obstetric Labor, Premature | Indomethacin | 4.59 | 6374098 | |
MESH:D010003 | Osteoarthritis | Indomethacin | 6.77 | 7009135 | |
MESH:D010003 | Osteoarthritis | Iron | 6.77 | 16640825 | |
MESH:D010014 | Osteolysis | Paclitaxel | 4.41 | 15867366 | |
MESH:D010018 | Osteomalacia | Phenobarbital | 3.80 | 17016548 | |
MESH:D010024 | Osteoporosis | Iron | 6.81 | 16640825 16648989 | |
MESH:D010024 | Osteoporosis | Vitamin D | 6.81 | 17882678 | |
MESH:D010051 | Ovarian Neoplasms | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 19.63 | 16211241 | |
MESH:D010051 | Ovarian Neoplasms | Arsenic | 19.63 | 17306315 | |
MESH:D010051 | Ovarian Neoplasms | arsenic trioxide | 19.63 | 16624393 19769630 12452020 | |
MESH:D010051 | Ovarian Neoplasms | decitabine | 19.63 | 19331143 19259094 | |
MESH:D010051 | Ovarian Neoplasms | Paclitaxel | 19.63 | 11161223 | |
MESH:D010051 | Ovarian Neoplasms | Tretinoin | 19.63 | 16936753 | |
MESH:D010051 | Ovarian Neoplasms | U 0126 | 19.63 | 16211241 | |
MESH:D010146 | Pain | Acetaminophen | 12.40 | 16870215 | |
MESH:D010146 | Pain | Indomethacin | 12.40 | 17440234 17627676 13679232 3291741 | |
MESH:D010146 | Pain | Tretinoin | 12.40 | 16870215 | |
MESH:D010146 | Pain | zileuton | 12.40 | 15935457 | |
MESH:D010149 | Pain, Postoperative | Indomethacin | 4.10 | 12538197 18702446 | |
MESH:D010190 | Pancreatic Neoplasms | arsenic trioxide | 13.77 | 15580305 | |
MESH:D010190 | Pancreatic Neoplasms | decitabine | 13.77 | 19294695 | |
MESH:D010190 | Pancreatic Neoplasms | Phenobarbital | 13.77 | 16965848 | |
MESH:D010190 | Pancreatic Neoplasms | Tetradecanoylphorbol Acetate | 13.77 | 15976015 | |
MESH:D010190 | Pancreatic Neoplasms | Tretinoin | 13.77 | 15976015 | |
MESH:D010195 | Pancreatitis | Fatty Acids, Nonesterified | 7.59 | 18983441 | |
MESH:D010195 | Pancreatitis | Indomethacin | 7.59 | 15028970 17883296 | |
MESH:D010212 | Papilloma | Hydrogen Peroxide | 12.58 | 12065085 | |
MESH:D010212 | Papilloma | Iron | 12.58 | 12065085 | |
MESH:D010212 | Papilloma | Tetradecanoylphorbol Acetate | 12.58 | 8330346 12065085 18404319 18922899 | |
MESH:D010235 | Paraganglioma | arsenic trioxide | 3.64 | 19927285 | |
MESH:D010257 | Paraneoplastic Syndromes | Indomethacin | 5.14 | 16537180 | |
MESH:D020447 | Parasomnias | Iron | 5.44 | 17352947 | |
MESH:D010300 | Parkinson Disease | Iron | 3.09 | 16563566 16640825 | |
MESH:D020734 | Parkinsonian Disorders | Indomethacin | 3.63 | 12349958 | |
MESH:D051302 | Paroxysmal Hemicrania | Indomethacin | 5.14 | 11903285 | |
MESH:D010382 | Peliosis Hepatis | 1-Naphthylisothiocyanate | 5.28 | 20133375 | |
MESH:D010437 | Peptic Ulcer | Indomethacin | 4.58 | 11148446 | |
MESH:D010518 | Periodontitis | Indomethacin | 4.34 | 17225004 | |
MESH:D010523 | Peripheral Nervous System Diseases | Arsenic | 3.64 | 16093927 | |
MESH:D016491 | Peripheral Vascular Diseases | Arsenic | 4.42 | 16905509 6392382 15371236 | |
MESH:D010538 | Peritonitis | Ozone | 8.72 | 16369182 | |
MESH:D010538 | Peritonitis | zileuton | 8.72 | 17371808 | |
MESH:D010900 | Pituitary Diseases | Iron | 5.09 | 16604332 | |
MESH:D011014 | Pneumonia | Lipopolysaccharides | 9.23 | 11605937 12224865 | |
MESH:D011014 | Pneumonia | Ozone | 9.23 | 18929643 18381685 18007984 | |
MESH:D011041 | Poisoning | Iron | 3.78 | 16604332 | |
MESH:D017499 | Porokeratosis | alitretinoin | 5.43 | 16144296 | |
MESH:D017119 | Porphyria Cutanea Tarda | Iron | 4.44 | 16640825 | |
MESH:D011230 | Precancerous Conditions | Phenobarbital | 3.14 | 2563599 | |
MESH:D011225 | Pre-Eclampsia | Iron | 3.98 | 16640825 | |
MESH:D047928 | Premature Birth | Indomethacin | 4.57 | 17000239 | |
MESH:D011297 | Prenatal Exposure Delayed Effects | Valproic Acid | 7.85 | 20603192 | |
MESH:D011297 | Prenatal Exposure Delayed Effects | vinclozolin | 7.85 | 18220299 18042343 19015723 | |
MESH:D055728 | Primary Myelofibrosis | decitabine | 4.17 | 17616702 | |
MESH:D011469 | Prostatic Diseases | vinclozolin | 4.37 | 18220299 | |
MESH:D011470 | Prostatic Hyperplasia | Calcitriol | 4.21 | 15572423 | |
MESH:D011471 | Prostatic Neoplasms | Arsenic | 1.97 | 16140617 | |
MESH:D011471 | Prostatic Neoplasms | arsenic trioxide | 1.97 | 19131511 | |
MESH:D011471 | Prostatic Neoplasms | Calcitriol | 1.97 | 15754350 16289102 12479363 18247401 16644109 | |
MESH:D011471 | Prostatic Neoplasms | Cholecalciferol | 1.97 | 17024972 | |
MESH:D011471 | Prostatic Neoplasms | Paclitaxel | 1.97 | 16729912 17172428 16356831 17136230 | |
MESH:D011472 | Prostatitis | vinclozolin | 4.37 | 18629315 | |
MESH:D011507 | Proteinuria | Arsenic | 12.50 | 21343184 | |
MESH:D011507 | Proteinuria | Indomethacin | 12.50 | 11849393 | |
MESH:D011507 | Proteinuria | Tretinoin | 12.50 | 16636307 | |
MESH:D011528 | Protozoan Infections | Iron | 5.44 | 16640825 | |
MESH:D011537 | Pruritus | zileuton | 4.58 | 17827870 19657356 | |
MESH:D019310 | Pseudolymphoma | Phenobarbital | 10.27 | 12752131 | |
MESH:D019310 | Pseudolymphoma | Valproic Acid | 10.27 | 12752131 11422049 | |
MESH:D011625 | Pterygium | Tretinoin | 4.23 | 16723453 | |
MESH:D011654 | Pulmonary Edema | zileuton | 4.85 | 18309904 | |
MESH:D015427 | Reperfusion Injury | zileuton | 3.96 | 15266012 9865762 | |
MESH:D012130 | Respiratory Hypersensitivity | Lipopolysaccharides | 3.34 | 10835634 | |
MESH:D012148 | Restless Legs Syndrome | Iron | 4.11 | 16930377 | |
MESH:D012208 | Rhabdomyosarcoma | decitabine | 15.50 | 19155313 | |
MESH:D012208 | Rhabdomyosarcoma | Tretinoin | 15.50 | 16283617 16116481 | |
MESH:D012208 | Rhabdomyosarcoma | Valproic Acid | 15.50 | 19155313 | |
MESH:D012220 | Rhinitis | zileuton | 4.35 | 20332717 | |
MESH:D012512 | Sarcoma, Ewing's | arsenic trioxide | 3.42 | 16646077 | |
MESH:D012559 | Schizophrenia | Valproic Acid | 1.98 | 19110320 15737665 | |
MESH:D012640 | Seizures | Phenobarbital | 4.70 | 3137016 11442880 16876388 4039156 | |
MESH:D012640 | Seizures | Valproic Acid | 4.70 | 1511512 15475178 3137016 17978042 14763951 16876388 11044598 11738929 | |
MESH:D003294 | Seizures, Febrile | Phenobarbital | 4.25 | 6407741 | |
MESH:D012852 | Sinusitis | zileuton | 4.95 | 10665187 | |
MESH:D012871 | Skin Diseases | Arsenic | 2.58 | 19834688 17453740 16702368 16759981 17938729 15952646 17050553 17548696 6392382 16353154 18709164 | |
MESH:D012878 | Skin Neoplasms | Arsenic | 14.80 | 17976673 19538983 17029826 16251483 17050553 15504454 | |
MESH:D012878 | Skin Neoplasms | Hydrogen Peroxide | 14.80 | 12065085 | |
MESH:D012878 | Skin Neoplasms | Iron | 14.80 | 12065085 | |
MESH:D012878 | Skin Neoplasms | Tetradecanoylphorbol Acetate | 14.80 | 18404319 8985016 8330346 11807781 12065085 | |
MESH:D012878 | Skin Neoplasms | Tretinoin | 14.80 | 16467112 | |
MESH:D020181 | Sleep Apnea, Obstructive | zileuton | 5.29 | 19118273 | |
MESH:D013119 | Spinal Cord Injuries | zileuton | 4.95 | 18059327 | |
MESH:D016135 | Spinal Dysraphism | Valproic Acid | 3.34 | 19490988 | |
MESH:D013226 | Status Epilepticus | Valproic Acid | 3.96 | 12833885 | |
MESH:D013272 | Stomach Diseases | Indomethacin | 9.34 | 17638125 15472012 16280098 10486359 16113693 17160473 18545984 17207306 16184426 10215738 18209964 15038085 10192188 | |
MESH:D013272 | Stomach Diseases | plaunotol | 9.34 | 10215738 | |
MESH:D013274 | Stomach Neoplasms | arsenic trioxide | 5.58 | 17007042 | |
MESH:D013274 | Stomach Neoplasms | decitabine | 5.58 | 19037991 | |
MESH:D013274 | Stomach Neoplasms | Indomethacin | 5.58 | 15609394 | |
MESH:D013274 | Stomach Neoplasms | Paclitaxel | 5.58 | 18506536 18396642 | |
MESH:D013274 | Stomach Neoplasms | Tretinoin | 5.58 | 17261132 | |
MESH:D013276 | Stomach Ulcer | Indomethacin | 3.10 | 16755016 16252198 16397915 12500499 17918041 18726076 11906479 11595431 17135157 12498302 18431645 18181030 18543354 11595415 15138204 12467913 10878458 15255614 12077510 16169175 18237397 16934674 10750652 11729361 16150113 14567935 17627676 18209962 15104355 11523592 1323529 17654042 10423059 18087811 16631530 17657623 17895592 11145282 17977527 18193104 18299717 12787963 | |
MESH:D013398 | Sudden Infant Death | Iron | 4.88 | 16640825 | |
MESH:D024801 | Tauopathies | Paclitaxel | 4.25 | 16930453 | |
MESH:D013921 | Thrombocytopenia | 1-Naphthylisothiocyanate | 8.40 | 20133375 | |
MESH:D013921 | Thrombocytopenia | Lipopolysaccharides | 8.40 | 15821434 | |
MESH:D013964 | Thyroid Neoplasms | 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide | 22.39 | 16940797 | |
MESH:D013964 | Thyroid Neoplasms | arsenic trioxide | 22.39 | 19014326 | |
MESH:D013964 | Thyroid Neoplasms | decitabine | 22.39 | 17967635 | |
MESH:D013964 | Thyroid Neoplasms | Indomethacin | 22.39 | 18791128 14736730 11352223 | |
MESH:D013964 | Thyroid Neoplasms | Phenobarbital | 22.39 | 1399818 | |
MESH:D013964 | Thyroid Neoplasms | Tretinoin | 22.39 | 17045167 16026305 | |
MESH:D014062 | Tongue Neoplasms | Tretinoin | 3.29 | 16051514 | |
MESH:D016171 | Torsades de Pointes | arsenic trioxide | 3.40 | 15213294 | |
MESH:D014178 | Translocation, Genetic | Valproic Acid | 4.66 | 17262798 | |
MESH:D014376 | Tuberculosis | Iron | 6.94 | 16597321 | |
MESH:D014376 | Tuberculosis | Tretinoin | 6.94 | 16040207 | |
MESH:D014456 | Ulcer | Indomethacin | 4.33 | 17380554 10574470 | |
MESH:D020194 | Unverricht-Lundborg Syndrome | Valproic Acid | 3.96 | 3119515 | |
MESH:D001749 | Urinary Bladder Neoplasms | Arsenic | 6.94 | 17976673 17306315 11144890 15987713 19322015 19429237 18640142 | |
MESH:D001749 | Urinary Bladder Neoplasms | arsenic trioxide | 6.94 | 11780464 20435036 12973940 12845720 | |
MESH:D001749 | Urinary Bladder Neoplasms | decitabine | 6.94 | 17616700 19087683 | |
MESH:D014564 | Urogenital Abnormalities | Valproic Acid | 4.09 | 8888407 | |
MESH:D014581 | Urticaria | Acetaminophen | 2.46 | 10982225 | |
MESH:D002583 | Uterine Cervical Neoplasms | Tretinoin | 3.18 | 16129372 | |
MESH:D014604 | Uveal Neoplasms | decitabine | 10.91 | 17785578 | |
MESH:D014604 | Uveal Neoplasms | Tretinoin | 10.91 | 16752155 | |
MESH:D014652 | Vascular Diseases | Arsenic | 4.17 | 17056641 | |
MESH:D014820 | Vitiligo | Tretinoin | 3.52 | 16761959 | |
MESH:D014839 | Vomiting | Indomethacin | 4.17 | 11897121 | |
MESH:D015430 | Weight Gain | Dietary Fats | 3.26 | 16723640 | |
MESH:D009396 | Wilms Tumor | Tretinoin | 3.49 | 16287080 |
Pathway ID | Pathway Name |
---|---|
KEGG:05146 | Amoebiasis |
KEGG:04514 | Cell adhesion molecules (CAMs) |
KEGG:04640 | Hematopoietic cell lineage |
REACT:604 | Hemostasis |
REACT:13552 | Integrin cell surface interactions |
KEGG:05140 | Leishmaniasis |
KEGG:04670 | Leukocyte transendothelial migration |
KEGG:04145 | Phagosome |
KEGG:04810 | Regulation of actin cytoskeleton |
KEGG:05150 | Staphylococcus aureus infection |
KEGG:05152 | Tuberculosis |